Williamson AL - Search Results

1

Construction and characterisation of a candidate HIV-1 subtype C DNA vaccine for South Africa.

van Harmelen JH, Shephard E, Thomas R, Hanke T, Williamson AL, Williamson C. van Harmelen JH, et al. Among authors: williamson al, williamson c. Vaccine. 2003 Oct 1;21(27-30):4380-9. doi: 10.1016/s0264-410x(03)00406-7. Vaccine. 2003. PMID: 14505921

2

HIV-1 subtypes in different risk groups in South Africa.

Williamson C, Engelbrecht S, Lambrick M, van Rensburg EJ, Wood R, Bredell W, Williamson AL. Williamson C, et al. Among authors: williamson al. Lancet. 1995 Sep 16;346(8977):782. doi: 10.1016/s0140-6736(95)91543-5. Lancet. 1995. PMID: 7658903 No abstract available.

3

An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa.

van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C. van Harmelen J, et al. Among authors: williamson al, williamson c. AIDS. 1997 Jan;11(1):81-7. doi: 10.1097/00002030-199701000-00012. AIDS. 1997. PMID: 9110079

4

Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.

Passmore JA, Burch VC, Shephard EG, Marais DJ, Allan B, Kay P, Rose RC, Williamson AL. Passmore JA, et al. Among authors: williamson al. J Med Virol. 2002 Jun;67(2):234-40. doi: 10.1002/jmv.2212. J Med Virol. 2002. PMID: 11992584

5

Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle.

Aspden K, van Dijk AA, Bingham J, Cox D, Passmore JA, Williamson AL. Aspden K, et al. Among authors: williamson al. Vaccine. 2002 Jun 21;20(21-22):2693-701. doi: 10.1016/s0264-410x(02)00203-7. Vaccine. 2002. PMID: 12034095

6

The development of HIV-1 subtype C vaccines for Southern Africa.

Williamson AL. Williamson AL. IUBMB Life. 2002 Apr-May;53(4-5):207-8. doi: 10.1080/15216540212648. IUBMB Life. 2002. PMID: 12120996 Free article. Review.

7

Human papillomavirus (HPV) infection in Southern Africa: prevalence, immunity, and vaccine prospects.

Williamson AL, Marais D, Passmore JA, Rybicki E. Williamson AL, et al. IUBMB Life. 2002 Apr-May;53(4-5):253-8. doi: 10.1080/15216540212654. IUBMB Life. 2002. PMID: 12121005 Free article. Review.

8

Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice.

Jaffray A, Shephard E, van Harmelen J, Williamson C, Williamson AL, Rybicki EP. Jaffray A, et al. Among authors: williamson c, williamson al. J Gen Virol. 2004 Feb;85(Pt 2):409-413. doi: 10.1099/vir.0.19396-0. J Gen Virol. 2004. PMID: 14769898

9

Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines.

Dennehy M, Williamson AL. Dennehy M, et al. Among authors: williamson al. Vaccine. 2005 Jan 26;23(10):1209-24. doi: 10.1016/j.vaccine.2004.08.039. Vaccine. 2005. PMID: 15652663 Review.

10

Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial.

Burgers WA, van Harmelen JH, Shephard E, Adams C, Mgwebi T, Bourn W, Hanke T, Williamson AL, Williamson C. Burgers WA, et al. Among authors: williamson al, williamson c. J Gen Virol. 2006 Feb;87(Pt 2):399-410. doi: 10.1099/vir.0.81379-0. J Gen Virol. 2006. PMID: 16432028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters